IPG
35
-4
KMB
28
-2
PPL
44
-5
FCX
40
-3
HES
62
3
WDC
40
-2
EQR
31
-2
DNB
60
-8
DVN
35
13
BBY
53
-3
MAT
63
5
VNO
50
-2
LH
43
-2
AES
37
-2
GOOGL
51
-2
AEP
59
5
VTR
32
-3
PG
32
-6
CVS
40
7
ROST
56
-5
IPG
35
-4
KMB
28
-2
PPL
44
-5
FCX
40
-3
HES
62
3
WDC
40
-2
EQR
31
-2
DNB
60
-8
DVN
35
13
BBY
53
-3
MAT
63
5
VNO
50
-2
LH
43
-2
AES
37
-2
GOOGL
51
-2
AEP
59
5
VTR
32
-3
PG
32
-6
CVS
40
7
ROST
56
-5
Financhill
Back

ProShares UltraShort Dow30 Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
46

DXD
ProShares UltraShort Dow30

Last Price:
$27.83
Seasonality Move:
-5.63%
Sell
2

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-6.74%
Sell
46
ProShares UltraShort Dow30 (DXD) is a Sell

Is ProShares UltraShort Dow30 a Buy, Sell or Hold?

  • The current ProShares UltraShort Dow30 [DXD] share price is $27.83. The Score for DXD is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • DXD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $40.59. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DXD Stock Price Chart

What is ProShares UltraShort Dow30's stock price today?

  • The ProShares UltraShort Dow30 share price today is $27.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DXD is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $40.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.

DXD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.38 Buy
Relative Strength Index (14 RSI): 65.21 Buy
Chaikin Money Flow: 534024 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.23 - 27.21) Buy
Bollinger Bands (100): (25.69 - 28.75) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.44 Sell
Relative Strength Index (14 RSI): 22.69 Sell
Chaikin Money Flow: -2576687 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.5 - 57.26) Sell
Bollinger Bands (100): (51.08 - 57.64) Sell

DXD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.06 Buy
20-day SMA: 26.58 Buy
50-day SMA: 26.17 Buy
200-day SMA: 29.62 Sell
8-day EMA: 27.06 Buy
20-day EMA: 26.63 Buy
50-day EMA: 26.54 Buy
200-day EMA: 29.46 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.44 Sell
20-day SMA: 52.35 Sell
50-day SMA: 55.3 Sell
200-day SMA: 51.01 Sell
8-day EMA: 48.54 Sell
20-day EMA: 51.52 Sell
50-day EMA: 53.69 Sell
200-day EMA: 49.87 Sell

ProShares UltraShort Dow30 Earnings Growth & DXD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

ProShares UltraShort Dow30 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):